Literature DB >> 332075

Morphological changes in yeasts as a result of the action of 5-fluorocytosine.

T Arai, Y Mikami, K Yokoyama, T Kawata, K Masuda.   

Abstract

The mode of action of 5-fluorocytosine on Candida albicans and Saccharomyces cerevisiae was studied with special reference to morphology and ultrastructure. Shortly after contact of yeast cells with 10 mug of 5-fluorocytosine per ml, marked enlargement of the cells occurred. The initial increase in cell size was almost the same with both yeast strains. As incubation proceeded, further increase in cell volume continued with C. albicans, whereas no further change in cell volume was observed with S. cerevisiae. An electron microscope examination of C. albicans cells after exposure to the drug revealed characteristic changes, consisting of an enlarged nucleus and a thin cell wall. The morphological changes were exactly comparable to those reported with inhibitors of deoxyribonucleic acid synthesis in mammalian cells and some bacteria.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 332075      PMCID: PMC429894          DOI: 10.1128/AAC.12.2.255

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  Macromolecular structure and morphology of native glycogen particles isolated from Candida albicans.

Authors:  H Yamaguchi; Y Kanda; K Iwata
Journal:  J Bacteriol       Date:  1974-10       Impact factor: 3.490

2.  Evidence for a common transport system for cytosine, adenine and hypoxanthine in Saccharomyces cerevisiae and Candida albicans.

Authors:  A Polak; M Grenson
Journal:  Eur J Biochem       Date:  1973-01-15

3.  Fungistatic activity, uptake and incorporation of 5-fluorocytosine in Candida albicans, as influenced by pyrimidines and purines. I. Reversal experiments.

Authors:  A Polak; H J Scholer
Journal:  Pathol Microbiol (Basel)       Date:  1973

4.  Fungistatic activity, uptake and incorporation of 5-fluorocytosine in Candida albicans, as influenced by pyrimidines and purines. II. Studies on distribution and incorporation.

Authors:  A Polak; H J Scholer
Journal:  Pathol Microbiol (Basel)       Date:  1973

Review 5.  Fluorinated pyrimidines.

Authors:  C Heidelberger
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1965

6.  Perspectives in antifungal antibiotics and therapeutics.

Authors:  T Arai
Journal:  Postepy Hig Med Dosw       Date:  1974 Jul-Aug       Impact factor: 0.270

Review 7.  Introduction to the biochemistry of D-arabinosyl nucleosides.

Authors:  S S Cohen
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1966

8.  [tRNA's from yeast having incorporated 5-fluorouracil arising from in vivo deamination of 5-fluorocytosine].

Authors:  R Giege; J H Weil
Journal:  Bull Soc Chim Biol (Paris)       Date:  1970-03-31

9.  Genetic and physiological aspects of resistance to 5-fluoropyrimidines in Saccharomyces cerevisiae.

Authors:  R Jund; F Lacroute
Journal:  J Bacteriol       Date:  1970-06       Impact factor: 3.490

10.  5-fluorocytosine resistance in Cryptococcus neoformans.

Authors:  E R Block; A E Jennings; J E Bennett
Journal:  Antimicrob Agents Chemother       Date:  1973-06       Impact factor: 5.191

View more
  4 in total

1.  Effects of antineoplastic agents on growth, morphology and metabolism of Torulopsis glabrata.

Authors:  M A Ghannoum
Journal:  Mycopathologia       Date:  1986-09       Impact factor: 2.574

2.  The effect of flucytosine on the germination of Candida albicans.

Authors:  W H Wain; A Polak
Journal:  Postgrad Med J       Date:  1979-09       Impact factor: 2.401

3.  Antibacterial activity of some alpha-substituted 2-methyl-5-nitrofurans.

Authors:  M A Ghannoum; M Thomson; C D Beadle; W R Bowman
Journal:  Folia Microbiol (Praha)       Date:  1988       Impact factor: 2.099

4.  New Mechanisms of Flucytosine Resistance in C. glabrata Unveiled by a Chemogenomics Analysis in S. cerevisiae.

Authors:  Catarina Costa; Andreia Ponte; Pedro Pais; Rui Santos; Mafalda Cavalheiro; Takashi Yaguchi; Hiroji Chibana; Miguel Cacho Teixeira
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.